Cited by 141
Bayer (Germany)
Publishes on Urinary Tract Infections Management, Antibiotics Pharmacokinetics and Efficacy, Urinary Bladder and Prostate Research. 13 papers and 281 citations.
Add your photo, update your bio, and get notified when your ranking changes.
In an open study, a group of 11 patients with asymptomatic urinary tract infections, caused by resistant Pseudomonas strains, were given 200 mg of ciprofloxacin per day for 1 week. All strains displayed an in vitro sensitivity to the drug. Complete clinical resolution was obtained in 8 patients and long-term eradication in 3. No adverse reactions and only minor and reversible laboratory changes were recorded. Ciprofloxacin could be a valuable oral drug in the treatment of severe urinary infections. However, more clinical studies on the development of resistance under therapy and with other dose schedules are indicated.